Gilberto Szarf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gilberto Szarf has a total of 653 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Kaiser Ururahy Nunes Fonseca
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
20 shared publications - Rodrigo Caruso Chate
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
18 shared publications - Patrícia Yokoo
Hospital Israelita Albert Einstein São Paulo SP Brazil
11 shared publications - Gustavo Borges da Silva Teles
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
10 shared publications - Walther Yoshiharu Ishikawa
Hospital Israelita Albert Einstein, Brazil
10 shared publications - Murilo Marques Almeida Silva
Hospital Israelita Albert Einstein, Brazil
8 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Elsevier in SSRN Electronic Journal
Multi-Task Deep Learning Model for the Automated Segmentation of Neuroimages in Real-World CT Scans
Background and Objective: Segmenting head structures in medical images is challenging due to anatomical heterogeneity and structural complexity. Multi-task learning can improve performance through shared representations and may help address these challenges. However, architectures such as U-Net can struggle with distorted anatomy, while 3D shape-learning approaches often increase computational cost, motivating efficient alternatives.Methods: We propose DeepCTE3D, a multi-task model based on an adapted U-Net architecture, called И-Net, for segmenting the intracranial space, lateral ventricles, and eyeballs from 3D CT images. The model was trained and evaluated on 559 real-world CT scans from newborns to adults, including cases with severe anatomical distortions such as enlarged ventricles, skull deformities, and abnormal eyeballs. We hypothesized that segmentation complexity and morphological heterogeneity affect learning performance and generalization within a multi-task framework.Results: DeepCTE3D achieved Dice similarity coefficients of 98.13% for the intracranial space, 80.76% for the lateral ventricles, and 87.73% for the eyeballs. Because of their greater morphological heterogeneity and segmentation complexity, the lateral ventricles served as a reference task. Compared with single-task models, the multi-task approach improved training convergence while maintaining comparable or superior performance, particularly enhancing generalization for challenging structures.Conclusions: DeepCTE3D effectively segmented complex head structures across diverse CT datasets, including anatomically distorted cases. The findings support the hypothesis that accounting for segmentation complexity and morphological heterogeneity improves model generalization, especially for highly variable structures. These results highlight the potential of multi-task learning to extend segmentation capabilities to additional head structures and support CT imaging applications, particularly in low-resource settings.
- 2 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMulti-Task Deep Learning Model for the Automated Segmentation of Neuroimages in Real-World CT Scans
Background and Objective: Segmenting head structures in medical images is challenging due to anatomical heterogeneity and structural complexity. Multi-task learning can improve performance through shared representations and may help address these challenges. However, architectures such as U-Net can struggle with distorted anatomy, while 3D shape-learning approaches often increase computational cost, motivating efficient alternatives.Methods: We propose DeepCTE3D, a multi-task model based on an adapted U-Net architecture, called И-Net, for segmenting the intracranial space, lateral ventricles, and eyeballs from 3D CT images. The model was trained and evaluated on 559 real-world CT scans from newborns to adults, including cases with severe anatomical distortions such as enlarged ventricles, skull deformities, and abnormal eyeballs. We hypothesized that segmentation complexity and morphological heterogeneity affect learning performance and generalization within a multi-task framework.Results: DeepCTE3D achieved Dice similarity coefficients of 98.13% for the intracranial space, 80.76% for the lateral ventricles, and 87.73% for the eyeballs. Because of their greater morphological heterogeneity and segmentation complexity, the lateral ventricles served as a reference task. Compared with single-task models, the multi-task approach improved training convergence while maintaining comparable or superior performance, particularly enhancing generalization for challenging structures.Conclusions: DeepCTE3D effectively segmented complex head structures across diverse CT datasets, including anatomically distorted cases. The findings support the hypothesis that accounting for segmentation complexity and morphological heterogeneity improves model generalization, especially for highly variable structures. These results highlight the potential of multi-task learning to extend segmentation capabilities to additional head structures and support CT imaging applications, particularly in low-resource settings.
- Open Access
- 1 October 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (10)
Posicionamento sobre o Uso dos Mapas Multiparamétricos na Caracterização Tecidual Avançada pela Ressonância Magnética Cardiovascular – 2026
1. Introdução As doenças cardiovasculares continuam representando a principal causa de morbimortalidade no Brasil, impondo um impacto expressivo tanto em termos de saúde pública quanto em custos socioeconômicos. Entre essas condições, as cardiomiopatias – tanto de origem isquêmica quanto não isquêmica – assumem papel de destaque pela sua elevada prevalência, diversidade etiológica e complexidade diagnóstica. O reconhecimento precoce e acurado dessas doenças é fundamental para direcionar intervenções terapêuticas adequadas, melhorar o prognóstico e reduzir eventos adversos. Posicionamento sobre o Uso [...] 1. Introdução As doenças cardiovasculares continuam representando a principal causa de morbimortalidade no Brasil, impondo um impacto expressivo tanto em termos de saúde pública quanto em custos socioeconômicos. Entre essas condições, as cardiomiopatias – tanto de origem isquêmica quanto não isquêmica – assumem papel de destaque pela sua elevada prevalência, diversidade etiológica e complexidade diagnóstica. O reconhecimento precoce e acurado dessas doenças é fundamental para direcionar intervenções terapêuticas adequadas, melhorar o prognóstico e reduzir eventos adversos. Posicionamento sobre o Uso
- 1 October 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (10)
Open AccessPosicionamento sobre o Uso dos Mapas Multiparamétricos na Caracterização Tecidual Avançada pela Ressonância Magnética Cardiovascular – 2026
1. Introdução As doenças cardiovasculares continuam representando a principal causa de morbimortalidade no Brasil, impondo um impacto expressivo tanto em termos de saúde pública quanto em custos socioeconômicos. Entre essas condições, as cardiomiopatias – tanto de origem isquêmica quanto não isquêmica – assumem papel de destaque pela sua elevada prevalência, diversidade etiológica e complexidade diagnóstica. O reconhecimento precoce e acurado dessas doenças é fundamental para direcionar intervenções terapêuticas adequadas, melhorar o prognóstico e reduzir eventos adversos. Posicionamento sobre o Uso [...] 1. Introdução As doenças cardiovasculares continuam representando a principal causa de morbimortalidade no Brasil, impondo um impacto expressivo tanto em termos de saúde pública quanto em custos socioeconômicos. Entre essas condições, as cardiomiopatias – tanto de origem isquêmica quanto não isquêmica – assumem papel de destaque pela sua elevada prevalência, diversidade etiológica e complexidade diagnóstica. O reconhecimento precoce e acurado dessas doenças é fundamental para direcionar intervenções terapêuticas adequadas, melhorar o prognóstico e reduzir eventos adversos. Posicionamento sobre o Uso
- Open Access
- 28 September 2026
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 24
30-year-old man presenting with chest pain and odynophagia for 2 days
- 28 September 2026
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 24
Open Access30-year-old man presenting with chest pain and odynophagia for 2 days
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Artificial Intelligence
- Vol. 8 (5)
What LUNA25 Teaches Us about AI for Lung Cancer Screening
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Artificial Intelligence
- Vol. 8 (5)
What LUNA25 Teaches Us about AI for Lung Cancer Screening
- Open Access
- 17 December 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 24, eRW0987
Computed tomography imaging features of major pulmonary and extrapulmonary complications of fibrotic lung diseases
Patients diagnosed with fibrosing interstitial lung disease are at risk of several complications, some of which may be life-threatening. Computed tomography imaging plays an important role in diagnosing these overlapping conditions. This article summarizes the computed tomography imaging features of the most common conditions associated with fibrosing interstitial lung diseases, categorized by involvement of the lung parenchyma or extra-pulmonary compartments. Some steps may help to recognize such complications, such as having knowledge of the underlying fibrotic lung disease, being
- 17 December 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 24, eRW0987
Open AccessComputed tomography imaging features of major pulmonary and extrapulmonary complications of fibrotic lung diseases
Patients diagnosed with fibrosing interstitial lung disease are at risk of several complications, some of which may be life-threatening. Computed tomography imaging plays an important role in diagnosing these overlapping conditions. This article summarizes the computed tomography imaging features of the most common conditions associated with fibrosing interstitial lung diseases, categorized by involvement of the lung parenchyma or extra-pulmonary compartments. Some steps may help to recognize such complications, such as having knowledge of the underlying fibrotic lung disease, being
- Open Access
- 28 November 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e88626
AI-Assisted Chest X-Ray Interpretation in Resource-Limited Settings: LuAna Stepped-Wedge Trial Protocol (Preprint)
Background: Artificial intelligence (AI) has the potential to transform chest radiography interpretation by enhancing diagnostic accuracy, identifying subtle findings, reducing errors, and helping prioritize patient care. Although chest radiography remains a cost-effective and widely used imaging tool, its effectiveness is limited by overlapping anatomy and variability in clinical expertise. Integrating AI can help overcome some of these challenges, especially in resource-constrained settings. However, robust validation in real-world clinical contexts is essential before widespread implementation. This study protocol evaluates whether AI assistance improves general practitioners’ ability to detect radiographic findings on chest radiography in adults with respiratory complaints or those undergoing treatment for respiratory diseases compared with unaided interpretation. Potential benefits include increased diagnostic safety, higher physician confidence, more efficient workflows, and expanded access to expert support in underserved areas. Objective: This study aims to evaluate whether AI assistance enhances physicians’ ability to detect key radiographic abnormalities, including consolidation or pulmonary opacity, pneumothorax, atelectasis, pleural effusion, and cardiomegaly. The primary outcome is the difference in physicians’ diagnostic accuracy (per examination) when assisted by the AI tool compared with usual practice, using expert radiologist consensus as the reference value. Methods: This study is a protocol for a multicenter, stepped-wedge, cluster-randomized clinical trial following the CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) extension and SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) guidelines. The intervention involves the diagnostic support solution for chest radiography, Lung Analysis (LuAna), an AI-powered chest X-ray interpretation tool developed in partnership with the Brazilian Ministry of Health. Across 9 cities in Brazil, clusters will transition monthly from unaided chest X-ray interpretation by general practitioners to AI-assisted interpretation, with performance benchmarked against thoracic radiologists. The stepped-wedge design ensures that all clusters receive the intervention, reflecting real-world coordination, enhancing acceptability, improving statistical power, and strengthening causal inference through repeated measures. Diagnostic performance will be compared with a reference standard established by thoracic radiologists. Results: This project was funded in October 2024 (following ethics approval by the institutional review board). Data collection commenced in January 2026 and is projected to be completed by September 2026, marking the end of the trial period. As of November 2025, 3 centers were fully prepared for enrollment initiation. The LuAna clinical trial is currently ongoing, with data analysis (including statistical analyses) forecasted to be finalized by November 2026. Results are expected to be published by January 2027. Conclusions: This intervention is expected to enhance clinical decision-making by supporting earlier treatment initiation and more appropriate diagnostic pathways for patients with respiratory symptoms while maintaining a favorable safety profile and high physician usability. Findings from this trial will provide real-world evidence on the clinical utility of AI-assisted chest radiography. If effective, LuAna may leverage its scalability and equity advantages to become a replicable model for integrating AI into routine imaging workflows worldwide, especially in regions with limited access to specialist care.
- 28 November 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e88626
Open AccessAI-Assisted Chest X-Ray Interpretation in Resource-Limited Settings: LuAna Stepped-Wedge Trial Protocol (Preprint)
Background: Artificial intelligence (AI) has the potential to transform chest radiography interpretation by enhancing diagnostic accuracy, identifying subtle findings, reducing errors, and helping prioritize patient care. Although chest radiography remains a cost-effective and widely used imaging tool, its effectiveness is limited by overlapping anatomy and variability in clinical expertise. Integrating AI can help overcome some of these challenges, especially in resource-constrained settings. However, robust validation in real-world clinical contexts is essential before widespread implementation. This study protocol evaluates whether AI assistance improves general practitioners’ ability to detect radiographic findings on chest radiography in adults with respiratory complaints or those undergoing treatment for respiratory diseases compared with unaided interpretation. Potential benefits include increased diagnostic safety, higher physician confidence, more efficient workflows, and expanded access to expert support in underserved areas. Objective: This study aims to evaluate whether AI assistance enhances physicians’ ability to detect key radiographic abnormalities, including consolidation or pulmonary opacity, pneumothorax, atelectasis, pleural effusion, and cardiomegaly. The primary outcome is the difference in physicians’ diagnostic accuracy (per examination) when assisted by the AI tool compared with usual practice, using expert radiologist consensus as the reference value. Methods: This study is a protocol for a multicenter, stepped-wedge, cluster-randomized clinical trial following the CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) extension and SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) guidelines. The intervention involves the diagnostic support solution for chest radiography, Lung Analysis (LuAna), an AI-powered chest X-ray interpretation tool developed in partnership with the Brazilian Ministry of Health. Across 9 cities in Brazil, clusters will transition monthly from unaided chest X-ray interpretation by general practitioners to AI-assisted interpretation, with performance benchmarked against thoracic radiologists. The stepped-wedge design ensures that all clusters receive the intervention, reflecting real-world coordination, enhancing acceptability, improving statistical power, and strengthening causal inference through repeated measures. Diagnostic performance will be compared with a reference standard established by thoracic radiologists. Results: This project was funded in October 2024 (following ethics approval by the institutional review board). Data collection commenced in January 2026 and is projected to be completed by September 2026, marking the end of the trial period. As of November 2025, 3 centers were fully prepared for enrollment initiation. The LuAna clinical trial is currently ongoing, with data analysis (including statistical analyses) forecasted to be finalized by November 2026. Results are expected to be published by January 2027. Conclusions: This intervention is expected to enhance clinical decision-making by supporting earlier treatment initiation and more appropriate diagnostic pathways for patients with respiratory symptoms while maintaining a favorable safety profile and high physician usability. Findings from this trial will provide real-world evidence on the clinical utility of AI-assisted chest radiography. If effective, LuAna may leverage its scalability and equity advantages to become a replicable model for integrating AI into routine imaging workflows worldwide, especially in regions with limited access to specialist care.
- Open Access
- 28 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
AI- Assisted Chest X-Ray Interpretation in Resource-Limited Settings: LuAna Stepped-Wedge Trial Protocol (Preprint)
BACKGROUND Artificial intelligence (AI) has the potential to transform chest radiography (CXR) interpretation by enhancing diagnostic accuracy, identifying subtle findings, reducing errors, and helping prioritize patient care. Although CXR remains a cost-effective and widely used imaging tool, its effectiveness is limited by overlapping anatomy and variability in clinical expertise. Integrating AI can help overcome some of these challenges, especially in resource-constrained settings. However, robust validation in real-world clinical contexts is essential before widespread implementation. This study protocol evaluates whether AI assistance improves general practitioners' ability to detect radiographic findings on CXR in adults with respiratory complaints or undergoing treatment for respiratory diseases, compared to unaided interpretation. Potential benefits include increased diagnostic safety, higher physician confidence, more efficient workflows, and expanded access to expert support in underserved areas. OBJECTIVE This project aims to evaluate whether AI assistance enhances physicians’ ability to detect key radiographic abnormalities— including consolidation or pulmonary opacity, pneumothorax, atelectasis, pleural effusion, and cardiomegaly. The primary outcome is the difference in physicians’ diagnostic accuracy (per examination) when assisted by the AI tool compared with usual practice, using the expert radiologist consensus as the reference value. METHODS This is a protocol for a multicenter, stepped-wedge, cluster-randomized clinical trial following the CONSORT-AI extension and SPIRIT-AI guidelines. The intervention involves the diagnostic support Solution for CXR - Lung Analysis (LuAna), an AI-powered chest X-ray interpretation tool developed in partnership with the Brazilian Ministry of Health. Across nine cities in Brazil, clusters will transition monthly from unaided chest X-ray interpretation by general practitioners to AI-assisted interpretation, with performance benchmarked against thoracic radiologists. The stepped-wedge design ensures all clusters receive the intervention, reflecting real-world coordination, enhancing acceptability, improving power, and strengthening causal inference through repeated measures. Diagnostic performance will be compared to a reference standard established by thoracic radiologists. RESULTS Thirteen research centers across Brazil will participate, covering all five regions and diverse healthcare settings, from primary care to specialized tuberculosis centers. Next steps involve finalizing regulatory approvals and starting participant enrolment once all sites are fully activated. CONCLUSIONS This intervention is expected to enhance clinical decision-making by supporting earlier treatment initiation and more appropriate diagnostic pathways for patients with respiratory symptoms, while maintaining a favorable safety profile and high physician usability. The findings from this trial will provide real-world evidence on the clinical utility of AI-assisted chest radiography. If effective, LuAna may leverage its scalability and equity advantages to become a replicable model for integrating AI into routine imaging workflows worldwide, especially in regions with limited access to specialist care. CLINICALTRIAL NCT06686251, Registered on 2024-11-13.
- 28 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAI- Assisted Chest X-Ray Interpretation in Resource-Limited Settings: LuAna Stepped-Wedge Trial Protocol (Preprint)
BACKGROUND Artificial intelligence (AI) has the potential to transform chest radiography (CXR) interpretation by enhancing diagnostic accuracy, identifying subtle findings, reducing errors, and helping prioritize patient care. Although CXR remains a cost-effective and widely used imaging tool, its effectiveness is limited by overlapping anatomy and variability in clinical expertise. Integrating AI can help overcome some of these challenges, especially in resource-constrained settings. However, robust validation in real-world clinical contexts is essential before widespread implementation. This study protocol evaluates whether AI assistance improves general practitioners' ability to detect radiographic findings on CXR in adults with respiratory complaints or undergoing treatment for respiratory diseases, compared to unaided interpretation. Potential benefits include increased diagnostic safety, higher physician confidence, more efficient workflows, and expanded access to expert support in underserved areas. OBJECTIVE This project aims to evaluate whether AI assistance enhances physicians’ ability to detect key radiographic abnormalities— including consolidation or pulmonary opacity, pneumothorax, atelectasis, pleural effusion, and cardiomegaly. The primary outcome is the difference in physicians’ diagnostic accuracy (per examination) when assisted by the AI tool compared with usual practice, using the expert radiologist consensus as the reference value. METHODS This is a protocol for a multicenter, stepped-wedge, cluster-randomized clinical trial following the CONSORT-AI extension and SPIRIT-AI guidelines. The intervention involves the diagnostic support Solution for CXR - Lung Analysis (LuAna), an AI-powered chest X-ray interpretation tool developed in partnership with the Brazilian Ministry of Health. Across nine cities in Brazil, clusters will transition monthly from unaided chest X-ray interpretation by general practitioners to AI-assisted interpretation, with performance benchmarked against thoracic radiologists. The stepped-wedge design ensures all clusters receive the intervention, reflecting real-world coordination, enhancing acceptability, improving power, and strengthening causal inference through repeated measures. Diagnostic performance will be compared to a reference standard established by thoracic radiologists. RESULTS Thirteen research centers across Brazil will participate, covering all five regions and diverse healthcare settings, from primary care to specialized tuberculosis centers. Next steps involve finalizing regulatory approvals and starting participant enrolment once all sites are fully activated. CONCLUSIONS This intervention is expected to enhance clinical decision-making by supporting earlier treatment initiation and more appropriate diagnostic pathways for patients with respiratory symptoms, while maintaining a favorable safety profile and high physician usability. The findings from this trial will provide real-world evidence on the clinical utility of AI-assisted chest radiography. If effective, LuAna may leverage its scalability and equity advantages to become a replicable model for integrating AI into routine imaging workflows worldwide, especially in regions with limited access to specialist care. CLINICALTRIAL NCT06686251, Registered on 2024-11-13.
- Open Access
- 25 November 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 23, eAE1552
Implementation of positron emission tomography radiopharmaceuticals labeled with Gallium-68 in a hospital radiopharmacy: experience with more than 7,500 patients
Highlights ■ In-house 68Ga radiopharmaceutical synthesis under GMP in a tertiary hospital radiopharmacy. ■ Over 7,500 patients underwent imaging with [68Ga]Ga- DOTATATE and [68Ga]Ga-PSMA-11. ■ This is the first radiopharmacy in Brazil to introduce [68Ga] Ga-DOTA-UBI, and [68Ga]Ga-FAPi-46. ABSTRACT In this study, we report the implementation of in-house synthesis of gallium-68 (68Ga)-labeled radiopharmaceuticals for positron emission tomography (PET) at a tertiary hospital radiopharmacy. [68Ga]Ga-DOTATATE and [68Ga]Ga-PSMA-11 were introduced into clinical practice in January 2014 and October 2015, respectively, following the
- 25 November 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 23, eAE1552
Open AccessImplementation of positron emission tomography radiopharmaceuticals labeled with Gallium-68 in a hospital radiopharmacy: experience with more than 7,500 patients
Highlights ■ In-house 68Ga radiopharmaceutical synthesis under GMP in a tertiary hospital radiopharmacy. ■ Over 7,500 patients underwent imaging with [68Ga]Ga- DOTATATE and [68Ga]Ga-PSMA-11. ■ This is the first radiopharmacy in Brazil to introduce [68Ga] Ga-DOTA-UBI, and [68Ga]Ga-FAPi-46. ABSTRACT In this study, we report the implementation of in-house synthesis of gallium-68 (68Ga)-labeled radiopharmaceuticals for positron emission tomography (PET) at a tertiary hospital radiopharmacy. [68Ga]Ga-DOTATATE and [68Ga]Ga-PSMA-11 were introduced into clinical practice in January 2014 and October 2015, respectively, following the
- Open Access
- 25 November 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 23, eAO1895
Pulmonary nodules near fissures in hepatocellular carcinoma: assessing their clinical significance
Highlights ■ Typical perifissural nodules remain radiologically stable with no metastatic potential. ■ Only two nodules progressed to metastasis (one atypical perifissural nodule and one non-perifissural nodule). ■ Atypical and non-perifissural nodules require closer follow-up. ■ Annual growth rate was a strong marker of malignancy. ABSTRACT Objective: To evaluate whether pulmonary nodules adjacent to fissures, particularly perifissural nodules detected on chest computed tomography in patients with hepatocellular carcinoma, can be reliably classified as benign based on their radiological characteristics. Methods:
- 25 November 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 23, eAO1895
Open AccessPulmonary nodules near fissures in hepatocellular carcinoma: assessing their clinical significance
Highlights ■ Typical perifissural nodules remain radiologically stable with no metastatic potential. ■ Only two nodules progressed to metastasis (one atypical perifissural nodule and one non-perifissural nodule). ■ Atypical and non-perifissural nodules require closer follow-up. ■ Annual growth rate was a strong marker of malignancy. ABSTRACT Objective: To evaluate whether pulmonary nodules adjacent to fissures, particularly perifissural nodules detected on chest computed tomography in patients with hepatocellular carcinoma, can be reliably classified as benign based on their radiological characteristics. Methods: